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Male meiotic germ cell including the spermatozoa represent a great challenge to the immune system, 
as they appear long after the establishment of normal immune tolerance mechanisms. The capacity of 
the testes to tolerate autoantigenic germ cells as well as survival of allogeneic organ engrafted in the 
testicular interstitium have led to consider the testis an immunologically privileged site. Disruption 
of this immune privilege following trauma, tumor, or autoimmune orchitis often results in male 
infertility. Strong evidence indicates that indoleamine 2,3-dioxygenase (IDO) has been implicated 
in fetal and allograft tolerance, tumor immune resistance, and regulation of autoimmune diseases. 
IDO and tryptophan 2,3-dioxygenase (TDO) catalyze the same rate-limiting step of tryptophan 
metabolism along a common pathway, which leads to tryptophan starvation and generation of 
catabolites collectively known as kynurenines. However, the relevance of tryptophan metabolism 
in testis pathophysiology has not yet been explored. Here we assessed the in vivo role of IDO/TDO 
in experimental autoimmune orchitis (EAO), a model of autoimmune testicular inflammation and 
immunologically impaired spermatogenesis. EAO was induced in adult Wistar rats with testicular 
homogenate and adjuvants. Control (C) rats injected with saline and adjuvants and normal untreated 
rats (N) were also studied. mRNA expression of IDO decreased in whole testes and in isolated Sertoli 
cells during EAO. TDO and IDO localization and level of expression in the testis were analyzed by 
immunostaining and Western blot. TDO is expressed in granulomas from EAO rats, and similar protein 
levels were observed in N, C, and EAO groups. IDO was detected in mononuclear and endothelial cells 
and reduced IDO expression was detected in EAO group compared to N and C rats. This phenomenon 
was concomitant with a significant reduction of IDO activity in EAO testis measured by tryptophan and 
kynurenine concentrations (HPLC). Finally, in vivo inhibition of IDO with 1-methyl-tryptophan increased 
severity of the disease, demonstrating down regulation of IDO-based tolerance when testicular immune 
regulation was disrupted. We present evidence that an IDO-based mechanism is involved in testicular 
immune privilege.
The testis is considered an immunoprivileged organ since it tolerates germ cell antigens appeared during the 
pubertal period, an event developing long after establishment of immunocompetence. Also, the testis itself 
induces tolerance after its transplantation to an allogenic recipient, and is conversely able to accept foreign cells 
without triggering immune rejection1.
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Multiple mechanisms are involved in testis immune privilege: a blood testis barrier modulates antigen and 
antibody traffic inside and outside seminiferous tubules (ST), secretion of immunosuppressor molecules (e.g. 
transforming growth factor [TGF] β, interferon [IFN] α, β) by somatic and germ cells and the presence of local 
and systemic regulatory T (Treg) cells induce a testicular immunosuppressive microenvironment2,3. Tung et al.4 
have shown that, in contrast with a previous paradigm, only some murine meiotic germ cell antigens are seques-
tered and are not tolerogenic. In contrast, non-sequestered germ cell antigens egress from normal tubules and 
interact with circulating antibodies, forming immune complexes at the wall of ST. Non-sequestered germ cell 
antigens originated from fragments discarded by spermatids during spermiogenesis maintain physiological tol-
erance dependent on Treg. Autoimmune responses to spermatic antigens occur in human infertility and after 
vasectomy as well as in experimental models of autoimmune orchitis. Moreover, many germ cell antigens are also 
expressed as cancer antigens in human testicular neoplasia.
Two decades ago Sertoli cells (SC) were characterized as immunosuppressor cells5,6 providing a protective 
microenvironment for some grafts in co-transplantation experiments7,8. Fallarino et al.9 demonstrated that iso-
lated neonatal porcine SC prevent and revert diabetes in non obese diabetic mice, being cell or insulin therapy 
unnecessary. This result was explained by the restitution of systemic immune tolerance dependent on efficient 
tryptophan metabolism in the xenografts.
Indoleamine-2,3-dioxygenase (IDO) and tryptophan 2,3-dioxygenase (TDO) are intracellular 
heme-containing enzymes that catalyze oxidative cleavage of L-tryptophan to produce kynurenines. Depletion of 
L-tryptophan and production of kynurenine can modulate adaptive immune response10,11.
In dendritic cell (DCs), IDO expression is normally maintained at low basal levels but can be rapidly induced 
by IFNγ12,13. The IFNγ–IDO mechanism limits microbial growth and reduces injurious hyperinflammatory 
responses in the host14. The TGFβ–IDO axis has a primary role in the generation and maintenance of Treg cells15–17. 
Thus, IDO has a chief role in peripheral generation of Treg cells both in physiology and pathophysiology. IDO 
activity contributes to maternal tolerance in pregnancy18, controls allograft rejection19,20, and protects against 
autoimmunity such as, trinitrobenzene sulfonic acid colitis21, rheumatoid arthritis22, granulomatous diseases14,23 
and allergy24,25.
Although several reviews mention IDO as a molecule involved in testis immune privilege, the only evidence 
supporting this concept is the expression of IDO in porcine SC and the ability of these cells to restore immune 
tolerance in NOD mice9. Functional studies are therefore lacking to show a potential physiological and/or patho-
logical role for IDO-mediated immunoregulation in testis.
With the aim of contributing to understanding of the role of IDO/TDO in testis immunoprivilege in phys-
iological and inflammatory conditions, we evaluated the expression, distribution, and activity of this molecule 
in the testis of untreated normal (N), control (C), and rats with experimental autoimmune orchitis induced by 
active immunization with sperm antigens and adjuvants. We studied a potential functional role for IDO in vivo by 
analyzing the incidence and severity of orchitis in immunized rats that received an IDO inhibitor.
Materials and Methods
Animals. Adult male inbred Wistar rats aged 50–70 days were purchased from Bioterio Central Facultad de 
Farmacia y Bioquímica (Buenos Aires, Argentina). Animals were kept at 22 °C with 14 h light, 10 h dark sched-
ule and fed standard food pellets and water ad libitum. The use of rats followed NIH guidelines for care and use 
of experimental animals, also approved by local committees (Comité Institucional para el Cuidado y Uso de 
Animales de Laboratorio (CICUAL)-Facultad de Medicina).
Induction of experimental autoimmune orchitis (EAO). Rats were actively immunized with syngeneic 
testicular homogenate (TH) emulsified with complete Freund’s adjuvant (CFA; Sigma-Aldrich, St Louis, MO, 
USA) into the hind footpads and in different sites of flanks and near the neck area (subcutaneously) as described 
previously26. The first two immunizations were followed by an intravenous injection of 1010 inactivated Bordetella 
pertussis (Bp) bacteria (strain 10536; kindly provided by Instituto Malbrán, Buenos Aires, Argentina), whereas 
the third was followed by an intraperitoneal injection of Bp at a concentration of 5 × 109. Rats of control (C) group 
received CFA and Bp, but no TH, otherwise following the same scheme. Normal (N) untreated rats were also 
studied. Rats were killed 50 days after the first immunization. Testes, epididymis and popliteal, inguinal, renal and 
iliac lymph nodes (LN) were removed, weighed, and processed as described below. Only rats developing orchitis 
after 50 days were studied (EAO rats).
Histopathology. Histopathology of testis and epididymis was evaluated in paraffin-embedded Bouin’s-fixed 
sections obtained from three different levels and stained with hematoxylin-eosin. To evaluate the severity of 
EAO, we used a score described previously27. This score was graded by evaluation of (a) percentage of ST with 
impairment of spermatogenesis, (b) degree of germ cell sloughing and (c) testicular/body weight ratio (T/Bw). 
Maximum EAO score is 10. Animals with a score equal to 0 were considered free of orchitis. Epididymal pathol-
ogy was graded by evaluation of caput, corpus, and cauda inflammation and sperm depletion using an established 
score28. Epididymal inflammation (epididymitis): 1–5 and sperm depletion: 0–2 represent the range of incremen-
tal inflammation and decrement of sperm, respectively.
Immunohistochemistry. Rabbit polyclonal antibodies anti-IDO that recognize at least rat and human 
IDO129 or anti-TDO (GeneTex, Irvine, CA, USA) were used to detect expression and localization of IDO and 
TDO proteins in acetone-fixed frozen testis and LN sections (7 µm thick). Sections were incubated with 5% nor-
mal goat serum, 0.03% Triton X-100 containing 4% bovine serum albumin (BSA) for IDO or with 5% skim milk 
and 0.01% Triton X-100 for TDO 30 min at room temperature, and treated with avidin/biotin blocking solution 
(Vector Lab., Burlingame, CA, USA) followed by overnight incubation with the primary antibody IDO (1/500) or 
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TDO (1/25) at 4 °C in a humidified chamber. A biotinylated goat anti-rabbit IgG (1/250, Vector Lab.) was used as 
secondary antibody. Endogenous peroxidase activity was blocked by treatment with 0.01% H2O2 in methanol for 
30 min. The reaction was amplified with the Vectastain Elite ABC Kit (Vector Lab.), and the reaction product was 
visualized by the addition of diaminobenzidine substrate (Vector Lab.). Sections were counterstained with hema-
toxylin. Negative controls were obtained by incubating sections with phosphate-buffered saline (PBS) instead of 
primary antibodies.
Co-expression of IDO1 and ED1, ED2 or CD31 was detected in methanol-fixed cryostat testis sections by 
indirect immunofluorescence. Mouse monoclonal antibodies anti-ED1 (1/30, BD Pharmingen, San Diego, CA, 
USA) or anti-ED2 (1/50, BD Pharmingen) recognize a cytoplasmic antigen in rat monocytes, macrophages, and 
dendritic cells or membrane antigen of tissue macrophages, respectively. Mouse CD31 antibody (1/25, Genway 
Biotech Inc., San Diego, CA, USA) recognizes endothelial cells. Sections were incubated with 5% normal don-
key serum followed by 120 min incubation with ED1 or ED2 antibodies or 5% normal horse serum followed by 
overnight incubation with CD31 antibody. Anti-cyanine 3 conjugated mouse IgG (1/500, Merck, Darmstadt, 
Germany) was used as secondary antibody. Then, sections were blocked as described above, followed by over-
night incubation with IDO1 antibody. Anti-fluorescein isothiocyanate conjugated rabbit IgG (1/50, Vector Lab.) 
was used as secondary antibody. Sections were counterstained with 4′,6-diamidine-2-phenylindole (DAPI). 
Negative controls were obtained by incubating sections with PBS instead of primary antibodies.
qRT-PCR. Total RNA was isolated from testes of adult rats using TRIzol reagent (Life Technologies, Carlsbad, 
CA, USA) according to manufacturer’s instructions. The qRT-PCR assays were performed using oligonucleo-
tide primers for 18S rRNA (5′-ACACGGACAGGATTGACAGATT; 5′-CGTTCGTTATCGGAATTAACCA) 
and rat IDO (5′-AGCACTGGAGAAGGCACTG and 5′- CGTGGAAAAAGGTGTCTGG). 18S rRNA was cho-
sen as housekeeping gene. Reactions were conducted using FastStart Universal SYBR Green Master Mix (Roche 
Diagnostic, Mannheim, Germany) and the CFX-96 touch sequence detector System (Bio-Rad, Hercules, CA, 
USA). Reaction conditions were as follows: 10 min at 95 °C (one cycle), followed by 40 cycles of 15 s at 95 °C, 
30 s at 55 °C and 1 min at 60 °C for 18S, or by 40 cycles of 15 s at 95 °C and 1 min at 60 °C for IDO. Following the 
mathematical model of Pfaffl30, the fold change of mRNA IDO expression was determined for each sample as 
described previously31.
Immunohistochemical analysis followed by laser capture microdissection and RT-PCR. A goat 
polyclonal anti-vimentin antibody (1/10, Santa Cruz Biotechnology, Dallas, Texas, USA) was used to identify 
Sertoli cells in testes paraffin embedded sections. An immunoperoxidase technique using the avidin-biotin system 
was applied as described above. Subsequently, laser capture microdissection (LCM) was performed. Laser energy 
of the Applied Biosystems (Bedford, MA, USA) Arcturus LCM equipment was used to circumscribe vimentin 
immunopositive Sertoli cells as previously described by Rossi31. Microdissected samples containing immunop-
ositive Sertoli cells were used for RT-PCR. Total RNA was isolated using TRIzol reagent (Life Technologies) 
according to the manufacturer’s instructions. Purity of total RNA isolated was assessed using specific markers 
of germ cells (VASA) and Sertoli cells (FSH-receptor). The following oligonucleotide primers were used for 
amplification of IDO (first set 5′-GCAGTAGAGCATCAAGACC and 5′- CGTGGAAAAAGGTGTCTGG, 
hemi-nested set 5′-AGCACTGGAGAAGGCACTG and 5′-CGTGGAAAAAGGTGTCTGG), VASA 
(5′-CCAAGAGAGGCGGCTATCGAGATG and 5′-AGAACCAAAAAGGCCAACCAGTGCG), and 
FSH-receptor (5′-CCTTGCTCCTGGTCTCCTTG and 5- GGAAGACCCTGTCAGAGC). 18S amplification was 
performed using the oligonucleotide primers previously described in qRT-PCR section. PCR conditions were 
95 °C for 5 min, followed by 30–45 cycles of 94 °C for 1 min, 60 °C (annealing temperature) for 1 min, 72 °C for 
1 min, and a final incubation at 72 °C for 5 min. PCR products were separated on 2% agarose gels and visualized 
with ethidium bromide.
Western blots. Expression of IDO and TDO proteins were evaluated in testis, in a pool of renal and iliac LN 
(testicular draining LN; TLN) and a pool of inguinal and popliteal LN (LN draining the site of immunization, 
ILN). ST were mechanically separated from testicular interstitial cell (IC) and homogenized in ice-cold lysis 
buffer as described previously32. LN were cut with scissors and incubated with the lysis buffer. 200 μg of proteins 
were resolved in a 10% SDS-polyacrylamide gel electrophoresis, electroblotted at 66 mA for 18 h onto PVDF 
membranes (Bio-Rad Laboratories) and transfer was monitored by Ponceau S staining. Membranes were blocked 
with 5% non-fat dry milk in TBS containing 0.1% Tween 20 for 1 h. Blots were probed overnight with a rabbit 
anti-IDO29 (1/100), rabbit anti-IDO2 (1/100) or anti-TDO (1/500, GeneTex) polyclonal antibody followed by 
anti-actin (1/6000; Sigma-Aldrich) polyclonal antibody. Blots were washed and incubated with a biotinylated 
goat anti-rabbit IgG (1/3000; Vector Lab.) followed by streptavidin-horseradish peroxidase conjugates (Chemicon 
International Inc, Millipore Co., Billerica, MA, USA). Proteins were visualized by enhanced chemiluminescence 
and images were captured using GeneSnap software (7.08.01 version) and analyzed with Gene Tools software 
(4.01.02 version) from SynGene (Synoptics Ltd, Frederick, MD, USA).
IDO/TDO activity assay. To detect IDO/TDO activity decapsulated testes, TLN and ILN were cut with scis-
sors. Samples were incubated with lysis buffer as described above and no protease inhibitors were added. Protein 
precipitation was performed by adding 70% perchloric acid to the supernatant. The suspension was left on ice 
for 15 min, and then centrifuged at 22,000 g for 10 min. The pellet was discarded and 100 μl of the supernatant 
was analyzed by HPLC. Kynurenine (Kyn) release and tryptophan (Trp) degradation were measured. Standard 
curves were generated with L-Kyn and L-Trp (Sigma-Aldrich) in the same solvent. The chromatographic system 
was equipped with a Phenomenex Luna 5 μm, C18, 250 mm × 4.60 mm column and an ultraviolet detector (UVIS 
204, Linear Instruments, Reno, USA). The wavelength was set at 360 nm for Kyn and at 278 nm for Trp. The 
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mobile phase composed of acetate buffer (15 mM, pH 4) (92%) and acetonitrile (8%) was pumped at a flow rate of 
1.0 ml min−1. Results were shown as the Kyn/Trp ratio.
Administration of 1- Methyl-Tryptophan (1-MT). Based on Hou and Muller33, we used IDO specific 
inhibitor 1- D- MT (Sigma-Aldrich). It was administered 5 days per week by oral gavage at 10 mg/dose (0.1 ml/
rat) during the immunization period (from day 0 to day 28) to rats immunized with TH and adjuvants. Another 
group of immunized rats received 0.1 ml of diluent solution (0.5% Methylcellulose, 0.5% Tween 80) (vehicle). 
Animals were killed 50 days after first immunization. Body weight was determined and testes and epididymis 
were removed and processed for histopathology.
Delayed type hypersensitivity (DTH). DTH was measured by a footpad swelling test performed at the 
end of the in vivo assay as previously described34.
Statistical analysis. Results are expressed as mean ± SEM. Comparisons between groups were assessed by 
the non-parametric Mann-Whitney U test or Kruskal–Wallis One-Way ANOVA. P values less than 0.05 were 
considered significant.
Results
Histopathology. As described previously26 rats immunized with TH and adjuvants developed autoimmune 
orchitis characterized by mild interstitial infiltration of lymphomononuclear cells intermingled with Leydig cells 
and multiple foci of damaged ST with different degrees of germ cell sloughing. Some rats with severe orchitis pre-
sented severe germ cell sloughing in most ST in which only SC and basal germ cells (mainly spermatogonia and 
few pre leptotene spermatocytes) remained attached to the tubular wall and granulomae.
mRNA expression of IDO decreased in whole testes and isolated SC during EAO. To understand 
the relevance of IDO in testicular immune-privilege, we first compared IDO mRNA expression of N testis with 
IDO mRNA levels in testis from C and EAO groups. By qRT-PCR, we observed that testicular IDO expression 
was down regulated in rats with orchitis compared to C and N groups. Testis from C and N groups presented 
similar IDO mRNA expression levels (Fig. 1).
Based on the fact that SC are considered the paradigmatic testicular somatic cells with an immune regulatory 
role, we evaluated IDO mRNA expression in SC isolated from N and EAO groups. LCM followed by RT-PCR 
analyses revealed visible PCR products only in SC from N testis (Fig. 2). In addition, expression of germ cell 
marker (VASA) was not seen in isolated SC (Fig. S1).
Expression and localization of IDO and TDO. Protein IDO1 expression was evaluated by Western blot 
analysis in testicular ST and IC fractions from N, C, and EAO groups. IDO content in the ST fraction isolated 
from EAO rats was significantly lower compared to N and C rats (Figs 3A and S2A). No significant differences in 
IDO1 content were observed in the IC fraction in the different groups studied (Figs 3B and S2B).
In order to examine which cell populations of the testis might be contributing to IDO1 expression, immu-
nohistochemistry was performed on testicular sections of N, C, and EAO groups. Intensity of IDO staining was 
similar in N (Fig. 4A–C (data not shown) rats. Positive staining was observed in the testicular interstitium of 
the three groups studied, localized mainly in the endothelium of blood vessels (Figs 4 and S3). In EAO rats mild 
IDO reactivity was also detected in mononuclear cells present in the testicular interstitium, identified as resident 
macrophages (ED2+ cells) and DC and inflammatory macrophages (ED1+ cells) (Fig. S3). Exceptionally, specific 
staining was detected in spermatid heads of ST (stages XI and XIV) from testes of N and C rats (data not shown).
Considering that TDO and IDO2 also catalyze the initial step of tryptophan catabolism and TDO and IDO2 
mRNA are expressed in testis35,38, we evaluated protein TDO and IDO2 expression. No significant differences in 
TDO and IDO2 content were detected by Western blot analysis in testis from N, C, and EAO groups (Figs 5 and 
S4).
Figure 1. Testicular mRNA expression of IDO. Testicular mRNA expression of IDO was determined by 
qRT-PCR in testes from normal, control, and orchitis (EAO) rats. Results were normalized to 18S rRNA 
housekeeping gene and expressed as fold change relative to testes of normal rats, to which a value of 1 was 
assigned. Values are mean ± SEM of relative expression units (RE) of 5 animals in each group. *P < 0.05.
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TDO localization was evaluated by indirect immunoperoxidase in testicular sections of N, C, and EAO 
groups. TDO reactivity was detected in cells with macrophage/dendritic morphology present in granulomas and 
in testicular interstitium from EAO rats (Fig. 6A,B). No staining was observed in sections of N (Fig. 6C) and C 
rats (data not shown).
IDO/TDO activity in testis. IDO/TDO activity was assessed by HPLC to measure concentrations of Trp 
and Kyn in supernatants collected from testicular and LN homogenates. IDO activity (Kyn/Trp ratio) was reduced 
in testis of the EAO group compared to N and C groups (Fig. 7).
In vivo inhibition of IDO increased severity of EAO. To elucidate the role of IDO in testicular immune 
regulation, we evaluated the impact of inhibiting IDO during EAO induction. As described in Materials and 
Methods, immunized rats were treated or not with a specific enzyme inhibitor 1-MT until euthanasia. Notably, 
rats treated with 1-MT during the immunization period developed orchitis with significantly increased severity 
(Fig. 8B). Testicular histopathology showed that vehicle group presented multifocal testicular damage charac-
terized by mild infiltration of mononuclear cells and foci of ST with different degrees of germ cell sloughing. In 
contrast, most rats treated with 1-MT presented extended areas of severely damaged ST presenting aspermato-
genesis (Fig. 8A).
Epididymis of EAO rats treated with 1-MT compared to EAO vehicle group showed a higher degree of inflam-
mation represented by interstitial immune cell infiltrates and similar sperm depletion in the tubular lumen 
(Fig. 8A). However quantitative data of epididymal pathology were not statistically different (Fig. 8B).
Body weight of rats treated with 1-MT did not differ from that of untreated rats suggesting that no appar-
ent detrimental effects were induced by IDO inhibition treatments (Body weight (g) mean ± SEM: 1-MT, 
464.00 ± 9.73; vehicle group, 488.90 ± 9.40).
We subsequently investigated effects of IDO inhibition on T cell mediated immunity by analyzing DTH 
response to testicular antigens. Footpad challenge for DTH was tested in rats treated with 1-MT or vehicle 50 
days after immunization. No significant differences in footpad swelling were observed between 1-MT and vehicle 
(Fig. S5). These results showed that both experimental groups reacted similarly to the antigen challenge inde-
pendently of 1-MT treatment.
Evaluation of IDO and TDO in lymph nodes. Since draining LN reflect immune cell microenviron-
ment of target organ, IDO1 and TDO expression was also evaluated in testicular draining LN and non-draining 
LN. Intense IDO staining was observed mainly in cells with macrophage/dendritic morphology present in the 
deep cortex and in the medullary cords of draining and non-draining LN. Endothelial cells from blood vessels 
also exhibited a slightly positive staining for IDO. The highest number of positive IDO cells was observed in 
Figure 2. IDO is expressed in Sertoli cells. Vimentin-immunoreactive Sertoli cells from testicular sections of 
normal (N) and orchitis (EAO) rats were isolated by Laser Capture Microdissection (LCM). Representative 
microphotographs show the same section before (A) and after (B) LCM). Bar: 50 µm. Isolated Sertoli cells were 
subsequently used to evaluate the mRNA expression of 18S rRNA (109 bp) and IDO (103 bp) by RT-PCR. Testis 
from N rats were used as positive control (C+).
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draining LN of EAO rats. Also, a higher number of IDO positive cells were observed in draining LN compared 
to non-draining LN (Fig. 9A). LN of N rats presented similar IDO expression compared to rats in C group (data 
not shown).
No significant differences in IDO and TDO content were detected comparing N, C, and EAO rats in lysates of 
draining and non-draining LN (Figs 9B and S6).
Regarding IDO/TDO activity in LN, no significant changes were detected in draining and non-draining LN 
of EAO rats compared to N and C groups (Fig. 10).
Discussion
Although tryptophan catabolism into kynurenine by the IDO enzyme has been proposed as a putative mecha-
nism in testicular immune tolerance, this possibility has never been evaluated in normal and pathological con-
ditions in rats. This hypothesis stimulated us to evaluate the role of IDO in testis homeostasis and inflammation 
(autoimmune orchitis) in which immune privilege is disrupted. We evaluated the expression and activity of IDO/
TDO in normal versus inflamed testis and assessed orchitis progression after treating rats immunized with sperm 
antigens and adjuvants with the IDO-specific inhibitor 1MT.
In the male reproductive tract, it has been described a null35,36 or negligible IDO mRNA and protein expres-
sion in the testis of mice37, contrasting with its high content in epididymis. More recently Jenabian et al.38 
determined IDO1 and IDO2 mRNA in human testis of antiretroviral therapy-treated HIV- infected and non 
infected individuals. Our data show that rat testes with normal histopathology in the normal and control groups 
Figure 3. IDO1 is expressed in different testicular fractions. Expression of IDO by seminiferous tubules (A) 
and interstitial cells (B) of normal, control, and orchitis (EAO) rats was analyzed by Western blot. Each bar 
represents the mean ± SEM of 6 animals. The blots were cropped and the full-length blots are presented in the 
supplementary information (Fig. S2). *P < 0.05.
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expressed IDO mRNA and IDO1 protein as analyzed by Western blot. By immunohistochemistry we observed 
that IDO1 + cells were found in the testicular interstitium mainly in endothelial cells, and also in mononuclear 
cells, as described for other organs39,40. The fact that we did not detect IDO1 in SC by immunohistochemistry 
but did identify IDO mRNA in isolated SC and IDO protein in seminiferous tubules by Western blot might be 
due to the different sensitivity of techniques. Prepuberal SC isolated from normal pig have been demonstrated to 
progressively produce IDO and prolong survival of co-grafts in different immunological settings9,41. As a relevant 
result, we observed IDO mRNA in SC from testis of normal untreated rats only but not in SC from rats with 
autoimmune orchitis. Notably, IDO mRNA and protein expression as well as IDO activity were reduced in testis 
from EAO rats, suggesting that testis inflammation is associated with downregulation of IDO expression and 
enzyme activity.
IFNγ produced in inflamed tissues is known to be potent IDO inducer because mammalian ido1 gene promoters 
contain IFN-stimulated response elements42. We previously reported the increase of IFNγ in conditioned medium of 
testicular macrophages27 and in the number of IFNγ-producing CD4+ T cells in rats with orchitis43. However, pres-
ent results do not reflect positive regulation of IDO by IFN. Also, ido1 gene transcription may not result in enhanced 
IDO enzyme activity due to posttranslational controls, such as nitric oxide (NO)44. We may speculate that in EAO, 
Figure 4. Immunohistochemistry of IDO1 in rat testis sections. Photomicrographs of adult testis cryostat 
sections immunostained with specific IDO antibody. Positive immunoreactivity can be observed in blood 
vessels of normal (A,B) and orchitis (EAO) (C,D) rats and also in mononuclear cells present in the testicular 
interstitium of EAO rats (D). Omission of primary anti-IDO1 antibody was used as a negative control (E).
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NO–IDO interaction limits IDO function considering that testicular NO increases in rats with autoimmune orchi-
tis45 and prevention of EAO development occurs by inhibition of the nitric oxide synthase-NO system46. Similarly, 
this interaction was also demonstrated in heart allografts in rats47 and in a model of collagen-induced arthritis48.
Figure 5. TDO and IDO2 expression in testis. Expression of TDO and IDO2 by seminiferous tubules (A), 
interstitial cells (B) and testis homogenate (C) of normal, control, and EAO rats was analyzed by Western 
blot. No changes in TDO and IDO2 expression were observed comparing the different groups. Each bar 
represents the mean ± SEM of 6 animals. The blots were cropped and the full-length blots are presented in the 
supplementary information (Fig. S4).
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Under inflammatory conditions, IDO1 has been demonstrated to be subjected to proteasomal degradation in 
DCs, which is driven by high-level production of IL6, changing these cells from tolerogenic to immunogenic49. A 
high content of IL6 was previously demonstrated in autoimmune orchitis in rats50,51.
Although the number of IDO1+ cells in EAO draining LN was higher than in N draining- and non-draining 
LN, no significant changes in IDO1 expression and activity between N, C, and EAO groups were observed in 
draining and non-draining LN. In contrast, in a murine model of collagen-induced arthritis in which the tissue 
target is a non-immune privileged site IDO expression in LN was significantly increased after arthritis onset48. 
Both results reinforce our hypothesis that testicular IDO immune-suppression function occurs through a local 
mechanism.
In contrast to IDO1, no difference in testicular IDO2 content was detected comparing N, C, and EAO groups. 
It has been reported that deletion of the Ido2 gene has no major impact on normal reproduction in the mouse52. 
Figure 6. Immunohistochemistry of TDO in rat testis sections. Photomicrographs of adult testis cryostat 
sections immunostained with specific TDO antibody. Positive immunoreactivity can be observed in cells with 
macrophage/dendritic morphology (arrowhead) present in granulomas (G) and in the testicular interstitium of 
EAO rats (A,B). Negative reactivity can be observed in normal rat (C). Omission of primary anti-TDO antibody 
was used as a negative control (D). ST: seminiferous tubule.
Figure 7. Evaluation of IDO/TDO activity. Testicular homogenates from EAO, control, and normal groups 
were used for measurement concentrations of kynurenine (Kyn) and tryptophan (Trp) by HPLC. IDO/TDO 
activity was expressed as the ratio of Kyn/Trp. Data are mean ± SEM of 6 animals. *P < 0.05.
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Testicular TDO content was also similar among different groups studied. Notably, in few rats with severe orchitis; 
we observed TDO expression in macrophages and dendritic-like cells in the periphery of granulomae, which wall 
off immunogenic apoptotic germ cells from other structures of the tissue. By immunohistochemistry, Britan et 
al.35 detected that TDO protein was present both in the intertubular tissue and in late differentiating germ cells 
of adult mouse testis
Finally, to elucidate the role of IDO in testicular immune tolerance in vivo, we evaluated the impact of the specific 
IDO inhibitor 1-MT administered during the immunization period, demonstrating that IDO inhibition increased 
the severity of EAO. Therefore tryptophan metabolism could play a critical role in homeostatic control of testicular 
immune privilege. Since EAO is associated with epididymitis26,32, and the absence of IDO generates inflammation in 
the caput epididymis53, we also evaluated epididymis. IDO inhibition had no impact on epididymis histopathology. 
By analyzing in vivo DTH response to spermatic antigens, we showed that 1-MT treatment did not modify cell medi-
ated immunity, thereby strengthening the hypothesis of a local mechanism of testicular IDO function as mentioned 
above in reference to LN results. Although they used a different experimental design of 1-MT administration, early 
results of Sakurai et al.54 and Kwidzinski et al.55 also showed that IDO inhibition exacerbates the clinical course of 
EAE, which supports a role for IDO in controlling T cell-mediated inflammation.
Figure 8. IDO blockade in vivo: administration of 1-Methyl-Tryptophan (1-MT). (A) Representative 
photomicrographs of paraffin testis and epididymis sections from immunized rats treated with vehicle or 1-MT. 
Rats from vehicle group presented focal testicular damage characterized by a moderate interstitial mononuclear 
cell infiltrate and several seminiferous tubules with different degrees of germ cell sloughing. In contrast, rats from 
1-MT group presented severe orchitis with large areas of aspermatogenic seminiferous tubules showing only 
spermatogonia and Sertoli cells attached to the tubular wall. Epididymal histopathology of rats from 1-MT group 
compared to vehicle group shows similar depletion of spermatozoa and increase of inflammatory cell infiltrate (*). 
H&E. (B) Severity of orchitis and epididymitis is expressed as score mean ± SEM of vehicle and 1-MT group rats.
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Although we did not explore the mechanisms of IDO function, its main functions are known to be depletion 
of tryptophan and production of bioactive tryptophan catabolites that would serve to suppress T-cell–mediated 
immune responses42,56.
Figure 9. Evaluation of IDO1 and TDO in lymph nodes (LN). (A) Photomicrographs of testicular draining 
and non draining LN cryostat sections immunostained with specific IDO antibody. IDO immunoreactivity can 
be observed in endothelial cells of blood vessels (asterisk) and cells with macrophage/dendritic morphology 
(arrowhead). Note a higher number of positive IDO cells in draining LN from EAO rats. Omission of primary 
anti-IDO1 antibody was used as a negative control. (B) Expression of IDO and TDO in LN of normal, control, 
and EAO rats was analyzed by Western blot. Each bar represents the mean ± SEM of 6 animals. The blots were 
cropped and the full-length blots are presented in the supplementary information (Fig. S6).
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Overall results highlight that IDO1 is an active enzyme expressed by rat testicular somatic cells which behaves 
as an immunosuppressor molecule able to modulate inflammatory immune response to spermatic antigens. Our 
in vivo findings provide new evidence that an IDO-based mechanism participates in testicular immune privilege.
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